http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0475971-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d3ba6f026ef5776ed3a79d2944f81a87
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-805
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-58
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-805
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08H1-02
filingDate 1990-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b23273d9fa85084f7d2d62ed1f08b6d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63890c029384f84f9bfd3bc425227a35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f69052451a6ef9fe01106edfd034b48a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a8a9316d26c8d7bce2c5eb5a74f557a7
publicationDate 1992-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0475971-A1
titleOfInvention HEMOGLOBIN COMPOSITION AND THEIR USE.
abstract Disclosed is a stroma-free hemoglobin composition having an advantageous combination of properties for use as a universally applicable blood plasma expanding agent etc, such as an oxygen affinity value desired, a desired vascular retention time and the absence of toxic side effects. Said composition comprises human hemoglobin cross-linked intramolecularly via beta chains, and polymerized. 2-nor-2 formylpyridoxal 5-phosphate or a bis-pyridoxal polyphosphate is preferably used for the intramolecular crosslinking via the beta chains, and glutaraldehyde is used for the polymerization of hemoglobin.
priorityDate 1989-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID99269
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226434007
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11294
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129156184
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129717562
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406078
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227744232
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129010842
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128993523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1050
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID40600
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205934
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226402551
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415608
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7242
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14323461
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9845
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226936252
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19036804
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129099985
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226936253
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID258342
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65042
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6171
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397425
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398631
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129798433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129840108
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411449

Total number of triples: 49.